Bird & Bird advises InGeneron on divestment of Eticur GmbH

Contacts

stefan muench module
Stefan Münch

Partner
Germany

I am a partner in our Corporate and M&A team in Munich and a member of our Tech & Comms and Life Sciences & Healthcare Sector Groups, offering our clients in-depth experience in all facets of corporate law (transactional and non-transactional), alongside a deep understanding of their sector and business.

Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.



Headquartered in Houston and Munich, InGeneron is a privately held company that was formed to innovate cell-based technologies for healthcare and life sciences research. Eticur has been one of the leading providers of high-quality testing, processing and storage of stem cells from the umbilical cord.

The following Bird & Bird lawyers advised InGeneron: Partner Stefan Münch and Associate Daniel Gloor (both Corporate/M&A, Munich).


News & Deals

More News & Deals
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More
Deal Bird & Bird advises Everystate on its seed funding round

Jul 30 2025

Read More
Deal Bird & Bird advises Marylebone Cricket Club on landmark London Spirit stake transfer

Jul 30 2025

Read More
Deal Bird & Bird advises Bpifrance's SPI 2 fund on Khimod's €23 million fundraising

Jul 29 2025

Read More
News Bird & Bird hires Restructuring & Insolvency team in Singapore

Jul 28 2025

Read More
Deal Bird & Bird advises Akiem on the acquisition, financing and leasing of a fleet of 14 battery-powered electric trains

Jul 22 2025

Read More